Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FCNBA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,095
Award facts
- Contract value 100% obligated
- $3,094.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,094.80 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. The award was issued on September 23, 2025, with an ultimate completion date of October 15, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois location. The delivery order carries no set-aside designation.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at approximately $500 million and valid through November 2026. The IDC authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Xolair (omalizumab) is a monoclonal antibody used in the treatment of moderate-to-severe asthma and other allergic conditions, representing a specialized pharmaceutical product within DMS Pharmaceutical Group's established portfolio of branded medications, biologics, and medical consumables supplied to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FCNBA?
SPE2DB25FCNBA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FCNBA worth?
The government has obligated $3,095 on SPE2DB25FCNBA.
Is contract SPE2DB25FCNBA an order under another contract?
Yes. SPE2DB25FCNBA is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNBA competed?
The extent of competition for SPE2DB25FCNBA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award